Encompass Health Corporation Operating Lease Cost
Encompass Health Corporation (EHC) reported Operating Lease Cost of $43.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-26
- Encompass Health Corporation operating lease, cost for the quarter ending 2019-12-31 was $18.10M.
- Encompass Health Corporation operating lease, cost for the quarter ending 2019-09-30 was $19.00M.
- Encompass Health Corporation operating lease, cost for the quarter ending 2019-06-30 was $18.30M.
- Encompass Health Corporation operating lease, cost for the quarter ending 2019-03-31 was $17.50M.
- Encompass Health Corporation operating lease, cost for fiscal 2025 was $43.40M, a 4.08% increase from fiscal 2024.
- Encompass Health Corporation operating lease, cost for fiscal 2024 was $41.70M, a 1.96% increase from fiscal 2023.
- Encompass Health Corporation operating lease, cost for fiscal 2023 was $40.90M, a 5.68% increase from fiscal 2022.
- Encompass Health Corporation operating lease, cost for fiscal 2022 was $38.70M, a 17.13% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $43.40M 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $41.70M 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | $40.90M 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | $38.70M 10-K · filed 2025-02-28 | ||||
| 2021-12-31 | $46.70M 10-K · filed 2024-02-28 | $66.00M 10-K · filed 2022-02-25 | |||
| 2020-12-31 | $50.20M 10-K · filed 2023-02-27 | $68.50M 10-K · filed 2021-02-26 | |||
| 2019-12-31 | $18.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $37.10M derived: sum of 2 quarters · filed 2022-02-25 | $55.40M derived: sum of 3 quarters · filed 2022-02-25 | $72.90M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $19.00M 10-Q · filed 2019-10-31 | $37.30M derived: sum of 2 quarters · filed 2019-10-31 | $54.80M 10-Q · filed 2019-10-31 | ||
| 2019-06-30 | $18.30M 10-Q · filed 2019-07-31 | $35.80M 10-Q · filed 2019-07-31 | |||
| 2019-03-31 | $17.50M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |